Blog

Oct 31, 2024, 14:31

Development of TLS in different tumor sites from patients with high-grade serous ovarian cancer – Cancer Research Institute

Cancer Research Institute shared a post on LinkedIn:

“Aiming to improve the understanding of immune cell organization in ovarian cancer, a new study from researchers including CRI-Irvington Postdoctoral Fellow Dr. Ayana Ruffin of Emory University and former CRI-V Foundation CLIP Investigator Dr. Tullia Bruno of University of Pittsburgh sheds light on the development of tertiary lymphoid structures (TLS) in different tumor sites from patients with high-grade serous ovarian cancer.

Explore their findings, and discover how their insights could eventually lead to new treatment approaches for ovarian cancer.”

Ayana Ruffin cancer cancer awareness cancer care Cancer Research Institute CRI Emory University fight against cancer Global fight against cancer OncoDaily Oncology tertiary lymphoid structures (TLS) TLS Tullia Bruno University of Pittsburgh

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial